[Treatment with cytostatic agents should be considered in colorectal cancer. It improves prognosis and quality of life].
Larsson
P A
PA
Kirurgkliniken, Helsingborgs lasarett.
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D010166:Palliative Care; D011379:Prognosis; D011788:Quality of Life; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology
D000964:Antimetabolites, Antineoplastic; D002955:Leucovorin; D005472:Fluorouracil
Cytostatikabehandling bör övervägas vid kolorektal cancer. Förbättrar både prognos och livskvalitet.